Home


    Fiscal Year Ended
In millions January 1,
2000
(53 weeks)
  December 26,
1998
(52 weeks)
  December 27,
1997
(52 weeks)

Cash flows from operating activities:
  Net earnings $635.1 $384.5 $88.8
  Adjustments required to reconcile net earnings
  to net cash provided by (used in)
  operating activities:
       Depreciation and amortization 277.9 249.7 242.6
       Merger, restructuring and other
       nonrecurring charges
188.6 466.4
       Deferred income taxes and other
       noncash items
124.8 80.6 (140.4)
       Extraordinary item, net of income tax benefit 17.1
  Change in assets and liabilities, excluding acquisitions:
       Increase in accounts receivable, net (48.9) (197.9) (82.5)
       Increase in inventories (255.0) (315.0) (566.1)
       Increase in other current assets (16.7) (18.5) (18.3)
       Increase in accounts payable 166.8 52.6 174.7
       Decrease in accrued expenses (37.7) (134.5) (232.3)
       Decrease in other assets and other
       long-term liabilities
(187.5) (69.1) (55.8)

Net cash provided by (used in) operating activities 658.8 221.0 (105.8)

Cash flows from investing activities:
Additions to property and equipment (493.5) (502.3) (341.6)
Acquisitions, net of cash (33.6) (62.2)
Proceeds from sale of businesses and
       other property and equipment
28.2 50.5 192.7
Proceeds from sale of investments 309.7

Net cash (used in) provided by investing activities (498.9) (514.0) 160.8

Cash flows from financing activities:
(Reductions in) additions to short-term
       borrowings
(324.5) 304.6 466.4
Proceeds from exercise of stock options 20.4 121.1 169.1
Additions to (reductions in) long-term debt 298.1 (41.9) (917.2)
Dividends paid (104.7) (102.5) (87.6)

Net cash (used in) provided by financing activities (110.7) 281.3 (369.3)

Net increase (decrease) in cash and cash
  equivalents
49.2 (11.7) (314.3)
Cash and cash equivalents at beginning of year 180.8 192.5 506.8

Cash and cash equivalents at end of year $230.0 $180.8 $192.5

See accompanying notes to consolidated financial statements.

Download this section in PDF format.

home

copyright 1999 CVS/pharmacy, Inc.
For Investor web site questions/comments, send e-mail to investorinfo@cvs.com